Another obesity-associated marker of elevated breast cancer risk, especially in the case of visceral fat, is fibroblast growth factor-2 (FGF2), which is released by adipose tissue. The gene discussed is FGF2; the disease is obesity due to melanocortin 4 receptor deficiency.